Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Javier J. Lepe
Observed names:
Javi Lepe,
Javier Lepe,
Lepe, Javier
Institutions:
University of California, Irvine,
University of California System
Observed institutions:
University of California, Irvine,
University of California System
ORCID:
0000-0001-8956-6999
Observed ORCID:
0000-0001-8956-6999
OpenAlex ID:
A5102810659
Cognitive complications of cancer and cancer-related treatments – Novel paradigms
2021
·
Naomi Lomeli
, Javier Lepe
, et al.
·
Neuroscience Letters
·
36
Transforming University of California, Irvine medical physiology instruction into the pandemic era
2020
·
Javier J. Lepe
, Arina Alexeeva
, et al.
·
FASEB BioAdvances
·
20
PDF
Dual targeting of the mitochondrial Lon peptidase 1 and the chymotrypsin-like proteasome activity as a potential therapeutic strategy in malignant astrocytoma models
2025
·
Christopher Douglas
, Shashi Jain
, et al.
·
Pharmacological Research
·
9
N-acetylcysteine prevents cisplatin-induced cognitive impairments in an ovarian cancer rat model
2024
·
Naomi Lomeli
, Diana C. Pearre
, et al.
·
Cancer Letters
·
8
PDF
Preclinical assessment of MAGMAS inhibitor as a potential therapy for pediatric medulloblastoma
2024
·
Zahra Motahari
, Javier J. Lepe
, et al.
·
PLoS ONE
·
4
Identification of new hit to lead magmas inhibitors as potential therapeutics for glioblastoma
2023
·
Bhaskar C. Das
, Javier J. Lepe
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
2
PDF
Discovery and Validation of Novel LonP1 and Proteasome Inhibitor in IDH1-R132H Malignant Astrocytoma Models
2023
·
Chris Douglas
, Naomi Lomeli
, et al.
·
SSRN Electronic Journal
·
2
A novel rat model of ovarian cancer and cisplatin chemotherapy-related cognitive impairment
2026
·
Naomi Lomeli
, Diana C. Pearre
, et al.
·
Brain Behavior & Immunity - Health
PDF
Deciphering LonP1’s role in glioblastoma: an alternative mechanism of treatment resistance
2026
·
Shashi Jain
, Dahlia A. Ordaz
, et al.
·
American Journal of Physiology-Cell Physiology
Table 1 from MAGMAS Inhibition Enhances Temozolomide Efficacy in Chemotherapy-Resistant Glioblastoma Models
2026
·
Javier J. Lepe
, Jennifer D. Tran
, et al.
Data from MAGMAS Inhibition Enhances Temozolomide Efficacy in Chemotherapy-Resistant Glioblastoma Models
2026
·
Javier J. Lepe
, Jennifer D. Tran
, et al.
Supplementary Figure S1 from MAGMAS Inhibition Enhances Temozolomide Efficacy in Chemotherapy-Resistant Glioblastoma Models
2026
·
Javier J. Lepe
, Jennifer D. Tran
, et al.
Figure 2 from MAGMAS Inhibition Enhances Temozolomide Efficacy in Chemotherapy-Resistant Glioblastoma Models
2026
·
Javier J. Lepe
, Jennifer D. Tran
, et al.
Supplementary Table S2 from MAGMAS Inhibition Enhances Temozolomide Efficacy in Chemotherapy-Resistant Glioblastoma Models
2026
·
Javier J. Lepe
, Jennifer D. Tran
, et al.
Figure 4 from MAGMAS Inhibition Enhances Temozolomide Efficacy in Chemotherapy-Resistant Glioblastoma Models
2026
·
Javier J. Lepe
, Jennifer D. Tran
, et al.
Figure 1 from MAGMAS Inhibition Enhances Temozolomide Efficacy in Chemotherapy-Resistant Glioblastoma Models
2026
·
Javier J. Lepe
, Jennifer D. Tran
, et al.
Figure 3 from MAGMAS Inhibition Enhances Temozolomide Efficacy in Chemotherapy-Resistant Glioblastoma Models
2026
·
Javier J. Lepe
, Jennifer D. Tran
, et al.
Supplementary Figure S3 from MAGMAS Inhibition Enhances Temozolomide Efficacy in Chemotherapy-Resistant Glioblastoma Models
2026
·
Javier J. Lepe
, Jennifer D. Tran
, et al.
Supplementary Table S1 from MAGMAS Inhibition Enhances Temozolomide Efficacy in Chemotherapy-Resistant Glioblastoma Models
2026
·
Javier J. Lepe
, Jennifer D. Tran
, et al.
Supplementary Figure S2 from MAGMAS Inhibition Enhances Temozolomide Efficacy in Chemotherapy-Resistant Glioblastoma Models
2026
·
Javier J. Lepe
, Jennifer D. Tran
, et al.
MAGMAS Inhibition Enhances Temozolomide Efficacy in Chemotherapy-Resistant Glioblastoma Models
2026
·
Javier J. Lepe
, Jennifer D. Tran
, et al.
·
Cancer Research Communications
Abstract 556: Inhibition of mitochondrial protein MAGMAS increases sensitivity to standard of care treatment.
2026
·
Javier J. Lepe
, Shashi Jain
, et al.
·
Cancer Research
Abstract 382: Exploring the role of LONP1 in lon-traditional mechanisms of glioblastoma resistance.
2026
·
Shashi Jain
, Dahlia A. Ordaz
, et al.
·
Cancer Research
Abstract 1250: N-acetylcysteine pharmacokinetics and neuroprotection in a translational ovarian cancer model of cancer-related cognitive impairment.
2026
·
Naomi Lomeli
, Diana C. Pearre
, et al.
·
Cancer Research
Biom-112. Magmas Silencing Enhances the Efficacy to Gbm Standard of Care: a Preclinical Study
2025
·
Javier Lepe
, Claire Chen
, et al.
·
Neuro-Oncology
PDF
Show more works
View as search
Works count:
34
Citation count:
83
H-index:
4
I10-index:
2
Year
Topic
Type